Abbott Share Buybacks decreased by 40.4% to $180.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 35.7%, from $280.00M to $180.00M. Over 4 years (FY 2021 to FY 2025), Share Buybacks shows a downward trend with a -21.1% CAGR.
High repurchases often signal management's confidence in the company's valuation or a strategy to improve earnings per share.
The cash outflow associated with the company buying back its own shares from the open market. This is a primary method f...
Common among mature, cash-generative companies; peers in the healthcare sector often balance this with R&D investment.
share_repurchases| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $471.00M | $579.00M | $974.00M | $2.31B | $5.00M | $798.00M | $685.00M | $540.00M | $426.00M | $2.00M | $259.00M | $226.00M | $3.00M | $751.00M | $315.00M | $280.00M | $6.00M | $305.00M | $302.00M | $180.00M |
| QoQ Change | — | +22.9% | +68.2% | +136.9% | -99.8% | >999% | -14.2% | -21.2% | -21.1% | -99.5% | >999% | -12.7% | -98.7% | >999% | -58.1% | -11.1% | -97.9% | >999% | -1.0% | -40.4% |
| YoY Change | — | — | — | — | -98.9% | +37.8% | -29.7% | -76.6% | >999% | -99.7% | -62.2% | -58.1% | -99.3% | >999% | +21.6% | +23.9% | +100.0% | -59.4% | -4.1% | -35.7% |